Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Comparative Genomic Identification of Unique Signal Transduction Pathways and Targets In Pediatric Burkitt Lymphoma (PBL)

Nancy S Day, PhD, Janet Ayello, MS, MT(ASCP), Ian Waxman, MD, Carmella van de Ven, MA, Megan S. Lim, MD, PhD, Sherrie L. Perkins, MD, PhD, Warren G. Sanger, PhD, Lauren Harrison, RN, MSN, Stan Goldman, MD, Mitchell S. Cairo, MD

Blood (2010) 116 (21): 631.

https://doi.org/10.1182/blood.V116.21.631.631

Published: 2010

Journal Articles

Inhibition of DLEU1 Following siRNA Transfection in Burkett’s Lymphoma (BL): Implication for Tumor Repressor Role of DLEU1 in C-Myc-Activated BL Lymphomagenesis

Nancy Day, Janet Ayello, MS, MT, Ian Waxman, MD, Evan Shereck, Catherine McGuinn, MD, Carmella van de Ven, MS, Megan S Lim, Sherrie L. Perkins, MD, PhD, Mitchell S. Cairo, MD

Blood (2008) 112 (11): 5335.

https://doi.org/10.1182/blood.V112.11.5335.5335

Published: 2008

Journal Articles

Correlation Between Increases in Apoptosis in Primary Mediastinal B-Cell Lymphoma (PMBL) and NF-κB Pathway Blockade: Bortezomib (BTZ), Small Molecule IKK Inhibitor ML120B and Combination Therapy Significantly Decrease NF-κB Family Member Protein Activation

Ian Waxman, MD, Dongxu Xie, Carmella van de Ven, Janet Ayello, MS, MT, Nancy Day, Megan S Lim, Sherrie L. Perkins, MD, PhD, Mitchell S. Cairo, MD

Blood (2008) 112 (11): 4983.

https://doi.org/10.1182/blood.V112.11.4983.4983

Published: 2008

Journal Articles

Quantitative Proteomic Identification of Novel Diagnostic Biomarkers and Therapeutic Targets for Classical Hodgkin Lymphoma.

Mihaela D. Chiselite, Damian Fermin, Venkatesha Basrur, Kevin P. Conlon, Charles Seiler, Ian Waxman, Mitchell S. Cairo, Kojo S.J. Elenitoba-Johnson, Megan S. Lim

Blood (2008) 112 (11): 1462.

https://doi.org/10.1182/blood.V112.11.1462.1462

Published: 2008

Journal Articles

Differential Gene Signature and Signaling Pathways in Childhood Burkitt (BL) vs Diffuse Large B-Cell Lymphoma (DLBCL).

Nancy S. Day, PhD, Janet Ayello, MS, Ian Waxman, MD, Evan Shereck, MD, Catherine McGuinn, MD, Julia Nemiroff, BS, Carmella van de Ven, MA, Mitchell S. Cairo, MD

Blood (2007) 110 (11): 4142.

https://doi.org/10.1182/blood.V110.11.4142.4142

Published: 2007

NARROW

Comparative Genomic Identification of Unique Signal Transduction Pathways and Targets In Pediatric Burkitt Lymphoma (PBL)

Inhibition of DLEU1 Following siRNA Transfection in Burkett’s Lymphoma (BL): Implication for Tumor Repressor Role of DLEU1 in C-Myc-Activated BL Lymphomagenesis

Correlation Between Increases in Apoptosis in Primary Mediastinal B-Cell Lymphoma (PMBL) and NF-κB Pathway Blockade: Bortezomib (BTZ), Small Molecule IKK Inhibitor ML120B and Combination Therapy Significantly Decrease NF-κB Family Member Protein Activation

Quantitative Proteomic Identification of Novel Diagnostic Biomarkers and Therapeutic Targets for Classical Hodgkin Lymphoma.

Differential Gene Signature and Signaling Pathways in Childhood Burkitt (BL) vs Diffuse Large B-Cell Lymphoma (DLBCL).

Email alerts

ASH Publications

American Society of Hematology

Comparative Genomic Identification of Unique Signal Transduction Pathways and Targets In Pediatric Burkitt Lymphoma (PBL)

Inhibition of DLEU1 Following siRNA Transfection in Burkett’s Lymphoma (BL): Implication for Tumor Repressor Role of DLEU1 in C-Myc-Activated BL Lymphomagenesis

Correlation Between Increases in Apoptosis in Primary Mediastinal B-Cell Lymphoma (PMBL) and NF-κB Pathway Blockade: Bortezomib (BTZ), Small Molecule IKK Inhibitor ML120B and Combination Therapy Significantly Decrease NF-κB Family Member Protein Activation

Quantitative Proteomic Identification of Novel Diagnostic Biomarkers and Therapeutic Targets for Classical Hodgkin Lymphoma.

Differential Gene Signature and Signaling Pathways in Childhood Burkitt (BL) vs Diffuse Large B-Cell Lymphoma (DLBCL).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only